These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21847706)

  • 1. Imaging ¹⁸F-fluorodeoxy glucose/¹¹C-methionine uptake decoupling for identification of tumor cell infiltration in peritumoral brain edema.
    Kinoshita M; Goto T; Arita H; Okita Y; Isohashi K; Kagawa N; Fujimoto Y; Kishima H; Shimosegawa E; Saitoh Y; Hatazawa J; Hashimoto N; Yoshimine T
    J Neurooncol; 2012 Jan; 106(2):417-25. PubMed ID: 21847706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
    No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
    Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
    J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-day protocol for
    Chang Y; Donglan Y; Xinchong S; Ganhua L; Bing Z; Yao L; Rutong Z; Qiao H; Xiangsong Z
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):68-74. PubMed ID: 32005511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltration.
    Kinoshita M; Arita H; Goto T; Okita Y; Isohashi K; Watabe T; Kagawa N; Fujimoto Y; Kishima H; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
    J Nucl Med; 2012 Nov; 53(11):1701-8. PubMed ID: 23000747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of
    He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
    BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
    Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
    Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
    J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
    J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
    Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T
    J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative MRI for analysis of peritumoral edema in malignant gliomas.
    Blystad I; Warntjes JBM; Smedby Ö; Lundberg P; Larsson EM; Tisell A
    PLoS One; 2017; 12(5):e0177135. PubMed ID: 28542553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas.
    Takano K; Kinoshita M; Arita H; Okita Y; Chiba Y; Kagawa N; Fujimoto Y; Kishima H; Kanemura Y; Nonaka M; Nakajima S; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):44-50. PubMed ID: 26381556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema.
    Kinoshita M; Goto T; Okita Y; Kagawa N; Kishima H; Hashimoto N; Yoshimine T
    J Neurooncol; 2010 Feb; 96(3):409-15. PubMed ID: 19696968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
    J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion tensor imaging provides an insight into the microstructure of meningiomas, high-grade gliomas, and peritumoral edema.
    De Belder FE; Oot AR; Van Hecke W; Venstermans C; Menovsky T; Van Marck V; Van Goethem J; Van den Hauwe L; Vandekerckhove M; Parizel PM
    J Comput Assist Tomogr; 2012; 36(5):577-82. PubMed ID: 22992609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
    Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1176-82. PubMed ID: 18388218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.